ContributorsPublishersAdvertisers

Efficacy of Mobocertinib Lowered by Dose Reductions in EGFR+ NSCLC

targetedonc.com
 2022-01-18

Cover picture for the articleDanny Nguyen, MD, discusses an analysis of efficacy and adverse events of mobocertinib in patients with EGFR-positive non–small cell lung cancer that was presented at the European Society for Medical Oncology 2021 Congress. Danny Nguyen, MD, assistant clinical professor at the department of medical oncology & therapeutics research...

www.targetedonc.com

Comments / 0

Comments / 0